No mention if the funding will be sufficient in and of itself to complete trials, and crunch data, but I'm hopeful that we'll be able to get S.P. traction now that some funding has been secured. However limited it might be, my hat's off to management. It's terrific p.r. at the very least, and an inducement to further private funding. We'll need the share price up considerably on positive test data before money can be raised with a stock offering, but we're headed in the right direction at long last.
News 
Market Data 
Discover 
